Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $13.7B |
| Sales growthchange from the year before | +27.9% |
| Operating marginshare of sales left after running the business | 5.3% |
| Net marginshare of sales kept as profit | 6.8% |
| Free-cash-flow marginspare cash generated per $100 of sales | 15.8% |
| Return on invested capitalprofit made on each $100 put into the business | 5.7% |
| Return on equityprofit vs. shareholders' accounting value | 9.3% |
| Change in share countnegative = the company is buying back its shares | +2.2% |
2 insiders sold $17.9M (all under pre-arranged plans) on the open market.
| Fang AndyDirector | Sold (plan)Aug 3 | 20,000 shat $200.30 · $4.0M |
| Tang StanleyDirector | Sold (plan)Aug 3 | 69,364 shat $200.61 · $13.9M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy